Pure Global AI
ANVISA registration 10033121102Valid until Jun 08, 2036

TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG)

ANVISA Registration Number: 10033121102BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDABECKMAN COULTER INCRisk Class IV
Verified
Device names
Technical name
TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG)
View exact technical-name matches →
PT: ANTICORPO TOTAL NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBCAG)
Commercial name
Família de Reagente, Calibradores e Controles Access HBc Ab
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
10033121102
Process Number
25351015892202631
CNPJ
42160812000144
Company information
Registration Holder
BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA
Manufacturer
BECKMAN COULTER INC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jun 08, 2026
Validity
08/06/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10033121102 and manufactured by BECKMAN COULTER INC. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Jun 08, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.